Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Wells Fargo Faces a Different Kind of Crisis in 2020

By Josh Enomoto, InvestorPlace Contributor

Learning the lessons of the Great Recession, the big banks are financially better off to handle this crisis. But for WFC stock, the question isn’t centered on amount but rather movement.

Vroom Is a Relevant Business Operating in an Awkward Time

By Josh Enomoto, InvestorPlace Contributor

Given the positive IPO market, perhaps it was no surprise that Vroom stock catapulted upward. Now, the real challenges lie ahead.

2 Pros and 2 Cons for Hailing Lyft for Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

Ride-sharing investments like Lyft stock immediately took a hit when the coronavirus first struck. Now, shares are moving higher as consumer sentiment returns but don’t get too eager before analyzing the pros and cons.

The Good, Bad, and Ugly of Luxury Retailer RH

By Josh Enomoto, InvestorPlace Contributor

On the surface, RH stock appears an easy buy case. However, investors looking to profit should consider this opportunity from all angles before jumping in.

2 Pros, 2 Cons for Buying AIM ImmunoTech

By Josh Enomoto, InvestorPlace Contributor

AIM stock has entered Wall Street’s consciousness due to the underlying biotech firm’s potential coronavirus treatment. However, will this be enough to keep shares moving higher?

Load More